N-Boc-3-hydroxy-8-azabicyclo[3.2.1]octane - CAS 478837-18-2
Catalog: |
BB026422 |
Product Name: |
N-Boc-3-hydroxy-8-azabicyclo[3.2.1]octane |
CAS: |
478837-18-2 |
Synonyms: |
3-hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylic acid tert-butyl ester; tert-butyl 3-hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylate |
IUPAC Name: | tert-butyl 3-hydroxy-8-azabicyclo[3.2.1]octane-8-carboxylate |
Description: | N-Boc-3-hydroxy-8-azabicyclo[3.2.1]octane (CAS# 478837-18-2) is a useful research chemical. |
Molecular Weight: | 227.30 |
Molecular Formula: | C12H21NO3 |
Canonical SMILES: | CC(C)(C)OC(=O)N1C2CCC1CC(C2)O |
InChI: | InChI=1S/C12H21NO3/c1-12(2,3)16-11(15)13-8-4-5-9(13)7-10(14)6-8/h8-10,14H,4-7H2,1-3H3 |
InChI Key: | SEGZJJSZYOEABC-UHFFFAOYSA-N |
LogP: | 1.84710 |
GHS Hazard Statement: | H301 (97.44%): Toxic if swallowed [Danger Acute toxicity, oral] |
Precautionary Statement: | P264, P270, P301+P310, P321, P330, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
WO-2021174176-A1 | Pyridazine dervatives for modulating nucleic acid splicing | 20200228 |
WO-2021161216-A1 | Farnesoid x receptor modulating compounds and methods of using the same | 20200211 |
KR-102293986-B1 | Isoquinolinone derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating poly(ADP-ribose)polymerase-1 related diseases containg the same as an active ingredient | 20191030 |
KR-20210052330-A | Isoquinolinone derivatives, preparation method thereof, and pharmaceutical composition for use in preventing or treating poly(ADP-ribose)polymerase-1 related diseases containg the same as an active ingredient | 20191030 |
WO-2021086077-A1 | Isoquinolinone derivative, preparation method therefor, and pharmaceutical composition, comprising same as active ingredient, for prevention or treatment of poly(adp-ribose)polymerase-1 (parp-1)-associated disease | 20191030 |
Complexity: | 271 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 227.15214353 |
Formal Charge: | 0 |
Heavy Atom Count: | 16 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 227.15214353 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 49.8 Å2 |
Undefined Atom Stereocenter Count: | 2 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.6 |
-
Catalog: BB044030
3-Hydroxy-2-hexanone
Detail
-
Catalog: BB001769
Ethyl (R)-(-)-Mandelate
Detail
-
Catalog: BB002564
(5R,6R,7S,8R,8aS)-6,7,8-Trihydroxy-5-(hydroxymethyl)hexahydroimidazo[1,2-a]pyridine-2,3-dione
Detail
-
Catalog: BB001393
4-Chloro-5-(hydroxymethyl)-2-(methylthio)pyrimidine
Detail
-
Catalog: BB000402
4-(Hydroxymethyl)benzaldehyde Oxime
Detail
-
Catalog: BB000104
2-(Boc-amino)-5-(hydroxymethyl)thiazole
Detail
-
Catalog: BB001222
(1-Phenyl-1H-1,2,3-triazol-4-yl)methanol
Detail
-
Catalog: BB003852
(2R,4S,5R)-5-Hydroxy-2-phenyl-1,3-dioxane-4-methanol
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Alcohols and Derivatives
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS